UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Breast cancer has the highest incidence and death rate among cancers in women
worldwide. In particular, metastatic estrogen receptor negative (ER–) breast cancer and …
worldwide. In particular, metastatic estrogen receptor negative (ER–) breast cancer and …
ERα, a key target for cancer therapy: A review
Y Liu, H Ma, J Yao - OncoTargets and therapy, 2020 - Taylor & Francis
Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-
independent tumors, and it is also essential for the development of these cancers. The …
independent tumors, and it is also essential for the development of these cancers. The …
YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
Hippo signaling restricts tissue growth by inhibiting the transcriptional effector YAP. Here we
uncover a role of Hippo signaling and a tumor suppressor function of YAP in estrogen …
uncover a role of Hippo signaling and a tumor suppressor function of YAP in estrogen …
Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis
X Xia, Y Liao, C Huang, Y Liu, J He, Z Shao, L Jiang… - Cancer letters, 2019 - Elsevier
Breast cancer is the most common malignancy in women around the world. Estrogen
receptor α (ERα) is expressed in approximately 70% of breast tumors, and considered as …
receptor α (ERα) is expressed in approximately 70% of breast tumors, and considered as …
The functions of TRIM56 in antiviral innate immunity and tumorigenesis
L Fu, X Zhou, Q Jiao, X Chen - International Journal of Molecular …, 2023 - mdpi.com
As a member of the TRIM (tripartite motif) protein family, TRIM56 can function as an E3
ubiquitin ligase. In addition, TRIM56 has been shown to possess deubiquitinase activity and …
ubiquitin ligase. In addition, TRIM56 has been shown to possess deubiquitinase activity and …
Molecular mechanisms of anti-estrogen therapy resistance and novel targeted therapies
Simple Summary Estrogen receptor-positive (ER+) breast cancer is a notable cause of
global death from breast cancer in premenopausal and postmenopausal women. Lethality is …
global death from breast cancer in premenopausal and postmenopausal women. Lethality is …
Role of K63-linked ubiquitination in cancer
L Cao, X Liu, B Zheng, C Xing, J Liu - Cell death discovery, 2022 - nature.com
Ubiquitination is a critical type of post-translational modifications, of which K63-linked
ubiquitination regulates interaction, translocation, and activation of proteins. In recent years …
ubiquitination regulates interaction, translocation, and activation of proteins. In recent years …
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells
Z Li, Y Li, D Han, X Wang, C Li, T Chen, W Li… - Cell death & …, 2023 - nature.com
Dysregulated ERα signaling is responsible for endocrine resistance and eventual relapse in
patients with estrogen receptor-positive (ER+) breast cancer. Thus, identifying novel ERα …
patients with estrogen receptor-positive (ER+) breast cancer. Thus, identifying novel ERα …
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
X Yang, Y Zhang, Z Xue, Y Hu, W Zhou, Z Xue… - Journal of Experimental …, 2022 - Springer
Background The tripartite motif (TRIM) family of proteins plays a key role in the
developmental growth and therapeutic resistance of many tumors. However, the regulatory …
developmental growth and therapeutic resistance of many tumors. However, the regulatory …
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
X Xia, C Huang, Y Liao, Y Liu, J He, Z Shao, T Hu… - Cell death & …, 2021 - nature.com
Breast cancer has the highest incidence and mortality in women worldwide. There are 70%
of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα …
of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα …